Renal Association Association of British Clinical Diabetologists
In the last 20 years or so huge advances have been made in the management of many diabetes related complications. However, the rates of diabetic nephropathy have not changed despite the implementation of several interventions. Despite NICE guidance and QoF targets, the management of this challenging condition remains an enigma.

This meeting brings together internationally renowned leaders in the field of diabetes related renal disease to discuss where we are now, where we want to be, and more importantly, what we have to do to get there.

WHO SHOULD ATTEND?

  • Consultants in diabetes
  • Consultants in renal disease
  • Trainees and specialist nurses in diabetes or nephrology who have an interest in diabetes related renal disease.
  • Also, those who are looking to learn more about the challenges that this condition poses and the innovations that are becoming available
Click here for general information for delegates.

This meeting has been funded by unrestricted educational grants from
Abbott Laboratories Ltd, Astra Zeneca/Bristol Myers Squibb Alliance,
Boehringer Ingelheim, Merck Sharp & Dohme, NovoNordisk, Sanofi Aventis.